{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:51:37Z","timestamp":1785754297095,"version":"3.56.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14514-0","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T08:26:13Z","timestamp":1751703973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive molecular biomarkers of radiosensitivity in adult glioma: a narrative review"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-8440","authenticated-orcid":false,"given":"Romina","family":"Abyaneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Bordbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-8396","authenticated-orcid":false,"given":"Sina","family":"Molavizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Fallahianshafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5830-8321","authenticated-orcid":false,"given":"Paola Anna","family":"Jablonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-5852","authenticated-orcid":false,"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-2019","authenticated-orcid":false,"given":"Reza","family":"Ghalehtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"key":"14514_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122664","author":"S Shah","year":"2024","unstructured":"Shah S, Nag A, Sachithanandam SV, Lucke-Wold B. Predictive and prognostic significance of molecular biomarkers in glioblastoma. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12122664.","journal-title":"Biomedicines"},{"issue":"Supplement5","key":"14514_CR2","first-page":"v1","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2012\u20132016. Neurooncology. 2019;21(Supplement5):v1\u2013100.","journal-title":"Neurooncology"},{"issue":"2","key":"14514_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41374-021-00667-6","volume":"102","author":"T Komori","year":"2022","unstructured":"Komori T. Grading of adult diffuse gliomas according to the 2021 WHO classification of tumors of the central nervous system. Lab Invest. 2022;102(2):126\u201333.","journal-title":"Lab Invest"},{"issue":"2","key":"14514_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"key":"14514_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803\u201320.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"14514_CR6","first-page":"1231","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neurooncol. 2021;23(8):1231\u201351.","journal-title":"Neurooncol"},{"issue":"10","key":"14514_CR7","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/0360-3016(79)90554-6","volume":"5","author":"OM Salazar","year":"1979","unstructured":"Salazar OM, Rubin P, Feldstein ML, Pizzutiello R. High dose radiation therapy in the treatment of malignant gliomas: final report. Int J Radiat Oncol Biol Phys. 1979;5(10):1733\u201340.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"14514_CR8","doi-asserted-by":"publisher","first-page":"vdae195","DOI":"10.1093\/noajnl\/vdae195","volume":"6","author":"A Sharifian","year":"2024","unstructured":"Sharifian A, Kazemian A, Farzin M, Amirkhani N, Farazmand B, Naderi S, et al. Postoperative neoadjuvant TEMozolomide followed by chemoradiotherapy versus upfront chemoradiotherapy for glioblastoma multiforme (NEOTEM) trial: interim results. Neuro-Oncol Adv. 2024;6(1):vdae195.","journal-title":"Neuro-Oncol Adv"},{"key":"14514_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-10-605","volume":"10","author":"J Kessler","year":"2010","unstructured":"Kessler J, Hahnel A, Wichmann H, Rot S, Kappler M, Bache M, Vordermark D. HIF-1\u03b1 inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer. 2010;10:1\u201311.","journal-title":"BMC Cancer"},{"issue":"5","key":"14514_CR10","first-page":"1881","volume":"53","author":"S Hasslacher","year":"2018","unstructured":"Hasslacher S, Schneele L, Stroh S, Langhans J, Zeiler K, Kattner P, et al. Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells. Int J Oncol. 2018;53(5):1881\u201396.","journal-title":"Int J Oncol"},{"key":"14514_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biocel.2015.09.001","volume":"68","author":"MP Gehring","year":"2015","unstructured":"Gehring MP, Kipper F, Nicoletti NF, Sperotto ND, Zanin R, Tamajusuku AS, et al. P2X7 receptor as predictor gene for glioma radiosensitivity and median survival. Int J Biochem Cell Biol. 2015;68:92\u2013100.","journal-title":"Int J Biochem Cell Biol"},{"key":"14514_CR12","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1007\/s00018-020-03704-7","volume":"78","author":"O Chen","year":"2021","unstructured":"Chen O, Manig F, Lehmann L, Sorour N, L\u00f6ck S, Yu Z, et al. Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells. Cell Mol Life Sci. 2021;78:3021\u201344.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"14514_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.radonc.2018.05.003","volume":"128","author":"B-S Jang","year":"2018","unstructured":"Jang B-S, Kim IA. A radiosensitivity gene signature and PD-L1 predict the clinical outcomes of patients with lower grade glioma in TCGA. Radiother Oncol. 2018;128(2):245\u201353.","journal-title":"Radiother Oncol"},{"key":"14514_CR14","doi-asserted-by":"publisher","first-page":"580335","DOI":"10.3389\/fimmu.2020.580335","volume":"11","author":"X-C Ding","year":"2020","unstructured":"Ding X-C, Wang L-L, Zhu Y-F, Li Y-D, Nie S-L, Yang J, et al. The change of soluble programmed cell death-ligand 1 in glioma patients receiving radiotherapy and its impact on clinical outcomes. Front Immunol. 2020;11:580335.","journal-title":"Front Immunol"},{"key":"14514_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ebiom.2018.01.027","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Shao Y, Jiang T, Ding Y, Xu B, Zheng X, et al. Radiotherapy upregulates programmed death ligand-1 through the pathways downstream of epidermal growth factor receptor in glioma. eBioMedicine. 2018;28:105\u201313.","journal-title":"eBioMedicine"},{"key":"14514_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093300","author":"MR Guda","year":"2020","unstructured":"Guda MR, Velpula KK, Asuthkar S, Cain CP, Tsung AJ. Targeting RGS4 ablates glioblastoma proliferation. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21093300.","journal-title":"Int J Mol Sci"},{"key":"14514_CR17","doi-asserted-by":"crossref","unstructured":"Zhu H, Qian C, Ge Y, Huang W, Zhang H, Zong D. RGS4 inhibits glioma cells sensitivity to radiotherapy and temozolomide by regulating ferroptosis. Int J Neurosci. 2024:1\u201315.","DOI":"10.1080\/00207454.2024.2401661"},{"issue":"6","key":"14514_CR18","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3892\/or_00001027","volume":"24","author":"C-H Hsieh","year":"2010","unstructured":"Hsieh C-H, Lee C-H, Liang J-A, Yu C-Y, Shyu W-C. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep. 2010;24(6):1629\u201336.","journal-title":"Oncol Rep"},{"issue":"2","key":"14514_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/neuonc\/not148","volume":"16","author":"RL Jensen","year":"2014","unstructured":"Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL. Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro-oncol. 2014;16(2):280\u201391.","journal-title":"Neuro-oncol"},{"issue":"1","key":"14514_CR20","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1038\/s41467-020-17885-z","volume":"11","author":"A Sharanek","year":"2020","unstructured":"Sharanek A, Burban A, Laaper M, Heckel E, Joyal J-S, Soleimani VD, Jahani-Asl A. OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation. Nat Commun. 2020;11(1):4116.","journal-title":"Nat Commun"},{"issue":"4","key":"14514_CR21","doi-asserted-by":"publisher","first-page":"e14709","DOI":"10.1111\/cns.14709","volume":"30","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Pei D, Wang M, Wang Q, Duan W, Wang L, et al. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2\/STAT3 axis. CNS Neurosci Ther. 2024;30(4):e14709.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"14514_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/09553002.2023.2235433","volume":"99","author":"W Huang","year":"2023","unstructured":"Huang W, Yuping H, Shuangyu Y, Xuefei X, Hualong Q, Ting S, Yang W. CA9 knockdown enhanced ionizing radiation-induced ferroptosis and radiosensitivity of hypoxic glioma cells. Int J Radiat Biol. 2023;99(12):1908\u201324.","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"14514_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00411-023-01021-8","volume":"62","author":"G Kashino","year":"2023","unstructured":"Kashino G, Kobashigawa S, Uchikoshi A, Tamari Y. VEGF affects mitochondrial ROS generation in glioma cells and acts as a radioresistance factor. Radiat Environ Biophys. 2023;62(2):213\u201320.","journal-title":"Radiat Environ Biophys"},{"issue":"1","key":"14514_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canrad.2017.06.013","volume":"22","author":"A Schernberg","year":"2018","unstructured":"Schernberg A, Dhermain F, Ammari S, Dumont SN, Domont J, Patrikidou A, et al. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients. Cancer Radiother. 2018;22(1):9\u201316.","journal-title":"Cancer Radiother"},{"issue":"8","key":"14514_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, et al. Bevacizumab plus radiotherapy\u2013temozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):709\u201322.","journal-title":"N Engl J Med"},{"issue":"8","key":"14514_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):699\u2013708.","journal-title":"N Engl J Med"},{"key":"14514_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.radonc.2020.09.005","volume":"154","author":"S Zheng","year":"2021","unstructured":"Zheng S, Wu Y, Li Z. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling. Radiother Oncol. 2021;154:36\u201344.","journal-title":"Radiother Oncol"},{"key":"14514_CR28","doi-asserted-by":"crossref","unstructured":"Park H, Nam KS, Lee HJ and Kim KS. Ionizing radiation-induced GDF15 promotes angiogenesis in human glioblastomamodels by promoting VEGFA expression through p-MAPK1\/SP1 signaling. Frontiers in oncology. 2022;12:p.801230.","DOI":"10.3389\/fonc.2022.801230"},{"issue":"11","key":"14514_CR29","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1158\/1078-0432.CCR-11-3091","volume":"18","author":"JS Jarboe","year":"2012","unstructured":"Jarboe JS, Anderson JC, Duarte CW, Mehta T, Nowsheen S, Hicks PH, et al. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma. Clin Cancer Res. 2012;18(11):3030\u201341.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"14514_CR30","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/neuonc\/not077","volume":"15","author":"WC You","year":"2013","unstructured":"You WC, Chiou SH, Huang CY, Chiang SF, Yang CL, Sudhakar JN, et al. Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma. Neuro Oncol. 2013;15(10):1342\u201352.","journal-title":"Neuro Oncol"},{"key":"14514_CR31","doi-asserted-by":"publisher","first-page":"640910","DOI":"10.3389\/fonc.2021.640910","volume":"11","author":"L Hu","year":"2021","unstructured":"Hu L, Cheng X, Binder Z, Han Z, Yin Y, O\u2019Rourke DM, et al. Molecular and clinical characterization of UBE2S in glioma as a biomarker for poor prognosis and resistance to chemo-radiotherapy. Front Oncol. 2021;11:640910.","journal-title":"Front Oncol"},{"issue":"8","key":"14514_CR32","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1158\/1535-7163.MCT-15-0247","volume":"14","author":"H Shen","year":"2015","unstructured":"Shen H, Hau E, Joshi S, Dilda PJ, McDonald KL. Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism. Mol Cancer Ther. 2015;14(8):1794\u2013804.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"14514_CR33","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nat Commun. 2020;11(1):3811.","journal-title":"Nat Commun"},{"issue":"2","key":"14514_CR34","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.18632\/oncotarget.6712","volume":"7","author":"DY Dadey","year":"2016","unstructured":"Dadey DY, Kapoor V, Khudanyan A, Urano F, Kim AH, Thotala D, Hallahan DE. The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma. Oncotarget. 2016;7(2):2080\u201392.","journal-title":"Oncotarget"},{"issue":"3","key":"14514_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1215\/15228517-2008-006","volume":"10","author":"HK Lee","year":"2008","unstructured":"Lee HK, Xiang C, Cazacu S, Finniss S, Kazimirsky G, Lemke N, et al. GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro Oncol. 2008;10(3):236\u201343.","journal-title":"Neuro Oncol"},{"issue":"8","key":"14514_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.cdd.4401428","volume":"11","author":"S Hara","year":"2004","unstructured":"Hara S, Nakashima S, Kiyono T, Sawada M, Yoshimura S, Iwama T, et al. p53-Independent ceramide formation in human glioma cells during gamma-radiation-induced apoptosis. Cell Death Differ. 2004;11(8):853\u201361.","journal-title":"Cell Death Differ"},{"issue":"1","key":"14514_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/neuonc\/2.1.16","volume":"2","author":"HK Shu","year":"2000","unstructured":"Shu HK, Julin CM, Furman F, Yount GL, Haas-Kogan D, Israel MA. Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation. Neuro Oncol. 2000;2(1):16\u201321.","journal-title":"Neuro Oncol"},{"issue":"10","key":"14514_CR38","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1158\/0008-5472.CAN-04-4202","volume":"65","author":"S Daido","year":"2005","unstructured":"Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, Kondo Y. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res. 2005;65(10):4368\u201375.","journal-title":"Cancer Res"},{"issue":"5","key":"14514_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/abbs\/gmp028","volume":"41","author":"W Zhuang","year":"2009","unstructured":"Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin. 2009;41(5):341\u201351.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"14514_CR40","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.7150\/thno.81999","volume":"13","author":"L Zeng","year":"2023","unstructured":"Zeng L, Zheng W, Liu X, Zhou Y, Jin X, Xiao Y, et al. SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes. Theranostics. 2023;13(11):3725\u201343.","journal-title":"Theranostics"},{"issue":"1","key":"14514_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40478-023-01527-8","volume":"11","author":"M Silginer","year":"2023","unstructured":"Silginer M, Papa E, Szab\u00f3 E, Vasella F, Pruschy M, Stroh C, et al. Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition. Acta Neuropathol Commun. 2023;11(1):41.","journal-title":"Acta Neuropathol Commun"},{"key":"14514_CR42","doi-asserted-by":"publisher","first-page":"101977","DOI":"10.1016\/j.tranon.2024.101977","volume":"45","author":"W Han","year":"2024","unstructured":"Han W, Zhou H, Zhang X, Li H, Han X, Su L, et al. HMGB2 is a biomarker associated with poor prognosis promoting radioresistance in glioma by targeting base excision repair pathway. Transl Oncol. 2024;45:101977.","journal-title":"Transl Oncol"},{"issue":"9","key":"14514_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1089\/cbr.2019.2829","volume":"34","author":"Q-J Liu","year":"2019","unstructured":"Liu Q-J, Lv J-X, Liu J, Zhang X-B, Wang L-B. Nucleobindin-2 promotes the growth and invasion of glioblastoma. Cancer Biotherapy Radiopharmaceuticals. 2019;34(9):581\u20138.","journal-title":"Cancer Biotherapy Radiopharmaceuticals"},{"issue":"1","key":"14514_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stemcr.2016.12.005","volume":"8","author":"HO King","year":"2017","unstructured":"King HO, Brend T, Payne HL, Wright A, Ward TA, Patel K, et al. RAD51 is a selective DNA repair target to radiosensitize glioma stem cells. Stem Cell Reports. 2017;8(1):125\u201339.","journal-title":"Stem Cell Reports"},{"issue":"12","key":"14514_CR45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3109\/09553002.2011.624152","volume":"87","author":"TA Kato","year":"2011","unstructured":"Kato TA, Okayasu R, Jeggo PA, Fujimori A. ASPM influences DNA double-strand break repair and represents a potential target for radiotherapy. Int J Radiat Biol. 2011;87(12):1189\u201395.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"14514_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/stem.261","volume":"28","author":"J Wang","year":"2010","unstructured":"Wang J, Wakeman TP, Lathia JD, Hjelmeland AB, Wang XF, White RR, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28(1):17\u201328.","journal-title":"Stem Cells"},{"key":"14514_CR47","doi-asserted-by":"publisher","first-page":"941657","DOI":"10.3389\/fonc.2022.941657","volume":"12","author":"AS Modrek","year":"2022","unstructured":"Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, et al. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Front Oncol. 2022;12:941657.","journal-title":"Front Oncol"},{"issue":"5","key":"14514_CR48","first-page":"1305","volume":"26","author":"J He","year":"2011","unstructured":"He J, Shan Z, Li L, Liu F, Liu Z, Song M, Zhu H. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas. Oncol Rep. 2011;26(5):1305\u201313.","journal-title":"Oncol Rep"},{"issue":"2","key":"14514_CR49","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1593\/neo.111794","volume":"14","author":"M Jamal","year":"2012","unstructured":"Jamal M, Rath BH, Tsang PS, Camphausen K, Tofilon PJ. The brain microenvironment preferentially enhances the radioresistance of CD133\u2009+\u2009glioblastoma stem-like cells. Neoplasia. 2012;14(2):150\u20138.","journal-title":"Neoplasia"},{"issue":"2","key":"14514_CR50","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.canlet.2015.12.012","volume":"371","author":"W Wang","year":"2016","unstructured":"Wang W, Long L, Wang L, Tan C, Fei X, Chen L, et al. Knockdown of cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro. Cancer Lett. 2016;371(2):274\u201384.","journal-title":"Cancer Lett"},{"issue":"8","key":"14514_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00018-022-04420-0","volume":"79","author":"Y Liang","year":"2022","unstructured":"Liang Y, Voshart D, Paridaen JT, Oosterhof N, Liang D, Thiruvalluvan A, et al. CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling. Cell Mol Life Sci. 2022;79(8):398.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"14514_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/cam4.2714","volume":"9","author":"WH Liu","year":"2020","unstructured":"Liu WH, Lin JC, Chou YC, Li MH, Tsai JT. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage. Cancer Med. 2020;9(1):350\u201360.","journal-title":"Cancer Med"},{"issue":"9","key":"14514_CR53","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.prp.2016.07.002","volume":"212","author":"E Guadagno","year":"2016","unstructured":"Guadagno E, Borrelli G, Califano M, Cal\u00ec G, Solari D, De Caro MDB. Immunohistochemical expression of stem cell markers CD44 and Nestin in glioblastomas: evaluation of their prognostic significance. Pathology-Research Pract. 2016;212(9):825\u201332.","journal-title":"Pathology-Research Pract"},{"issue":"1","key":"14514_CR54","first-page":"253","volume":"30","author":"K-C Wei","year":"2010","unstructured":"Wei K-C, Huang C-Y, Chen P-Y, Feng L-Y, Wu T-WE, Chen S-M, et al. Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res. 2010;30(1):253\u20139.","journal-title":"Anticancer Res"},{"key":"14514_CR55","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S233423","author":"D Si","year":"2020","unstructured":"Si D, Yin F, Peng J, Zhang G. High expression of CD44 predicts a poor prognosis in glioblastomas. Cancer Manag Res. 2020. https:\/\/doi.org\/10.2147\/CMAR.S233423.","journal-title":"Cancer Manag Res"},{"issue":"23","key":"14514_CR56","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3390\/cells11233917","volume":"11","author":"I Berglar","year":"2022","unstructured":"Berglar I, Hehlgans S, Wehle A, Roth C, Herold-Mende C, R\u00f6del F, et al. Chrdl1 regulates stemness in glioma stem-like cells. Cells. 2022;11(23):3917.","journal-title":"Cells"},{"issue":"12","key":"14514_CR57","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/cancers10120512","volume":"10","author":"J-C Lin","year":"2018","unstructured":"Lin J-C, Tsai J-T, Chao T-Y, Ma H-I, Liu W-H. The STAT3\/Slug axis enhances radiation-induced tumor invasion and cancer stem-like properties in radioresistant glioblastoma. Cancers. 2018;10(12):512.","journal-title":"Cancers"},{"issue":"6","key":"14514_CR58","first-page":"3141","volume":"7","author":"G-S Lin","year":"2014","unstructured":"Lin G-S, Chen Y-P, Lin Z-X, Wang X-F, Zheng Z-Q, Chen L. STAT3 Serine 727 phosphorylation influences clinical outcome in glioblastoma. Int J Clin Exp Pathol. 2014;7(6):3141.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"14514_CR59","doi-asserted-by":"publisher","first-page":"e0137703","DOI":"10.1371\/journal.pone.0137703","volume":"10","author":"Y Lee","year":"2015","unstructured":"Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J, et al. FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2. PLoS One. 2015;10(10):e0137703.","journal-title":"PLoS One"},{"issue":"2","key":"14514_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.stemcr.2014.12.006","volume":"4","author":"S-H Kim","year":"2015","unstructured":"Kim S-H, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, et al. Ezh2 protects glioma stem cells from radiation-induced cell death in a MELK\/FOXM1-dependent manner. Stem Cell Reports. 2015;4(2):226\u201338.","journal-title":"Stem Cell Reports"},{"issue":"60","key":"14514_CR61","doi-asserted-by":"publisher","first-page":"31637","DOI":"10.18632\/oncotarget.25827","volume":"9","author":"V Gouaz\u00e9-Andersson","year":"2018","unstructured":"Gouaz\u00e9-Andersson V, Gh\u00e9rardi M-J, Lemari\u00e9 A, Gilhodes J, Lubrano V, Arnauduc F, et al. FGFR1\/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker. Oncotarget. 2018;9(60):31637.","journal-title":"Oncotarget"},{"issue":"10","key":"14514_CR62","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-15-2058","volume":"76","author":"V Gouaz\u00e9-Andersson","year":"2016","unstructured":"Gouaz\u00e9-Andersson V, Delmas C, Taurand M, Martinez-Gala J, Evrard S, Mazoyer S, et al. FGFR1 induces glioblastoma radioresistance through the PLC\u03b3\/Hif1\u03b1 pathway. Cancer Res. 2016;76(10):3036\u201344.","journal-title":"Cancer Res"},{"issue":"2","key":"14514_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yexcr.2016.04.012","volume":"344","author":"Y-C Hsu","year":"2016","unstructured":"Hsu Y-C, Kao C-Y, Chung Y-F, Lee D-C, Liu J-W, Chiu M. Activation of Aurora A kinase through the FGF1\/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells. Exp Cell Res. 2016;344(2):153\u201366.","journal-title":"Exp Cell Res"},{"issue":"10","key":"14514_CR64","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ncb2579","volume":"14","author":"LK Povlsen","year":"2012","unstructured":"Povlsen LK, Beli P, Wagner SA, Poulsen SL, Sylvestersen KB, Poulsen JW, et al. Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012;14(10):1089\u201398.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"14514_CR65","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3892\/or.2013.2614","volume":"30","author":"W Zhou","year":"2013","unstructured":"Zhou W, Sun M, Li G-H, Wu Y-Z, Wang Y, Jin F, et al. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells. Oncol Rep. 2013;30(4):1793\u2013801.","journal-title":"Oncol Rep"},{"issue":"3","key":"14514_CR66","doi-asserted-by":"publisher","first-page":"e91216","DOI":"10.1371\/journal.pone.0091216","volume":"9","author":"X Guan","year":"2014","unstructured":"Guan X, Vengoechea J, Zheng S, Sloan AE, Chen Y, Brat DJ, et al. Molecular subtypes of glioblastoma are relevant to lower grade glioma. PLoS One. 2014;9(3):e91216.","journal-title":"PLoS One"},{"issue":"1","key":"14514_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.31661\/jbpe.v0i0.1223","volume":"12","author":"S Babaloui","year":"2022","unstructured":"Babaloui S, Najafi M, Mozdarani H, Borhani S, Jaberi R, Aghili M. Radiosensitization of glioma cells by Temozolomide (TMZ): a colony formation assay. J Biomed Phys Eng. 2022;12(1):43\u201350.","journal-title":"J Biomed Phys Eng"},{"issue":"2","key":"14514_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/neuonc\/nop020","volume":"12","author":"AL Rivera","year":"2010","unstructured":"Rivera AL, Pelloski CE, Gilbert MR, Colman H, De La Cruz C, Sulman EP, et al. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro Oncol. 2010;12(2):116\u201321.","journal-title":"Neuro Oncol"},{"issue":"1","key":"14514_CR69","first-page":"9461402","volume":"2017","author":"P Tini","year":"2017","unstructured":"Tini P, Nardone V, Pastina P, Battaglia G, Miracco C, Sebaste L, et al. Patients affected by unmethylated O (6)-Methylguanine\u2010DNA methyltransferase glioblastoma undergoing radiochemotherapy May benefit from moderately Dose\u2010Escalated radiotherapy. Biomed Res Int. 2017;2017(1):9461402.","journal-title":"Biomed Res Int"},{"issue":"6","key":"14514_CR70","first-page":"719","volume":"48","author":"R Ma","year":"2018","unstructured":"Ma R, Zheng G, Shao C, Liu J, Lv H, Zhang G. Downregulation of miR-196b promotes glioma cell sensitivity to Temozolomide chemotherapy and radiotherapy. Ann Clin Lab Sci. 2018;48(6):719\u201325.","journal-title":"Ann Clin Lab Sci"},{"key":"14514_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062960","author":"E Schnabel","year":"2021","unstructured":"Schnabel E, Knoll M, Schwager C, Warta R, Mock A, Campos B, et al. Prognostic value of microRNA-221\/2 and 17\u201392 families in primary glioblastoma patients treated with postoperative radiotherapy. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22062960.","journal-title":"Int J Mol Sci"},{"key":"14514_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101327","author":"S Wu","year":"2022","unstructured":"Wu S, Xu J, Li G, Jin X. Integrating radiosensitivity gene signature improves glioma outcome and radiotherapy response prediction. Medicina (B Aires). 2022. https:\/\/doi.org\/10.3390\/medicina58101327.","journal-title":"Medicina (B Aires)"},{"issue":"37","key":"14514_CR73","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1038\/sj.onc.1206701","volume":"22","author":"P Dent","year":"2003","unstructured":"Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene. 2003;22(37):5885\u201396.","journal-title":"Oncogene"},{"issue":"1","key":"14514_CR74","doi-asserted-by":"publisher","first-page":"e23551","DOI":"10.1002\/jbt.23551","volume":"38","author":"M Zhang","year":"2024","unstructured":"Zhang M, Wang Z, Wu Y, Chen M, Li J, Liu G. Hypoxia-induced factor\u20101\u03b1 promotes radioresistance of esophageal cancer cells by transcriptionally activating LINC01116 and suppressing miR\u20103612 under hypoxia. J Biochem Mol Toxicol. 2024;38(1):e23551.","journal-title":"J Biochem Mol Toxicol"},{"key":"14514_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030542","author":"AL Ch\u00e9deville","year":"2021","unstructured":"Ch\u00e9deville AL, Madureira PA. The role of hypoxia in glioblastoma radiotherapy resistance. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13030542.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"14514_CR76","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-020-00916-7","volume":"8","author":"Y Matsumoto","year":"2020","unstructured":"Matsumoto Y, Ichikawa T, Kurozumi K, Otani Y, Fujimura A, Fujii K, et al. Annexin A2\u2013STAT3\u2013Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma. Acta Neuropathol Commun. 2020;8(1):42.","journal-title":"Acta Neuropathol Commun"},{"key":"14514_CR77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3389\/fphys.2013.00400","volume":"4","author":"O Sedlakova","year":"2014","unstructured":"Sedlakova O, Svastova E, Takacova M, Kopacek J, Pastorek J, Pastorekova S. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors. Front Physiol. 2014;4:400.","journal-title":"Front Physiol"},{"issue":"2","key":"14514_CR78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-004-4204-7","volume":"74","author":"KE Hovinga","year":"2005","unstructured":"Hovinga KE, Stalpers LJA, van Bree C, Donker M, Verhoeff JJC, Rodermond HM, et al. Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines\u2013 a clue to radioresistance?? J Neurooncol. 2005;74(2):99\u2013103.","journal-title":"J Neurooncol"},{"key":"14514_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061383","author":"QT Bui","year":"2021","unstructured":"Bui QT, Hong JH, Kwak M, Lee JY, Lee PC. Ubiquitin-conjugating enzymes in cancer. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061383.","journal-title":"Cells"},{"key":"14514_CR80","doi-asserted-by":"publisher","first-page":"979537","DOI":"10.3389\/fonc.2022.979537","volume":"12","author":"V Ruiz-Rodado","year":"2022","unstructured":"Ruiz-Rodado V, Dowdy T, Lita A, Kramp T, Zhang M, Shuboni-Mulligan D, et al. Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant Astrocytoma mouse model. Front Oncol. 2022;12:979537.","journal-title":"Front Oncol"},{"issue":"1","key":"14514_CR81","doi-asserted-by":"publisher","first-page":"e54060","DOI":"10.1371\/journal.pone.0054060","volume":"8","author":"RN Vellanki","year":"2013","unstructured":"Vellanki RN, Zhang L, Volchuk A. OASIS\/CREB3L1 is induced by endoplasmic reticulum stress in human glioma cell lines and contributes to the unfolded protein response, extracellular matrix production and cell migration. PLoS One. 2013;8(1):e54060.","journal-title":"PLoS One"},{"key":"14514_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020159","author":"SS Shah","year":"2019","unstructured":"Shah SS, Rodriguez GA, Musick A, Walters WM, de Cordoba N, Barbarite E, et al. Targeting glioblastoma stem cells with 2-Deoxy-D-glucose (2-DG) potentiates radiation-induced unfolded protein response (UPR). Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11020159.","journal-title":"Cancers (Basel)"},{"key":"14514_CR83","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11302-012-9319-2","volume":"8","author":"MP Gehring","year":"2012","unstructured":"Gehring MP, Pereira TCB, Zanin RF, Borges MC, Filho AB, Battastini AMO, et al. P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line. Purinergic Signal. 2012;8:729\u201339.","journal-title":"Purinergic Signal"},{"issue":"8","key":"14514_CR84","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1158\/1535-7163.MCT-09-0201","volume":"8","author":"FA Dungey","year":"2009","unstructured":"Dungey FA, Caldecott KW, Chalmers AJ. Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90. Mol Cancer Ther. 2009;8(8):2243\u201354.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"14514_CR85","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ijrobp.2008.07.031","volume":"72","author":"FA Dungey","year":"2008","unstructured":"Dungey FA, L\u00f6ser DA, Chalmers AJ. Replication-dependent radiosensitization of human glioma cells by inhibition of Poly(ADP-ribose) polymerase: mechanisms and therapeutic potential. Int J Radiat Oncol Biol Phys. 2008;72(4):1188\u201397.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"14514_CR86","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1111\/jcmm.15435","volume":"24","author":"WJ Zeng","year":"2020","unstructured":"Zeng WJ, Cheng Q, Wen ZP, Wang JY, Chen YH, Zhao J, et al. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. J Cell Mol Med. 2020;24(17):9613\u201326.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"14514_CR87","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molonc.2011.05.001","volume":"5","author":"M Mannino","year":"2011","unstructured":"Mannino M, Chalmers AJ. Radioresistance of glioma stem cells: intrinsic characteristic or property of the \u2018microenvironment-stem cell unit\u2019? Mol Oncol. 2011;5(4):374\u201386.","journal-title":"Mol Oncol"},{"issue":"5","key":"14514_CR88","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1002\/ctm2.186","volume":"10","author":"S Qu","year":"2020","unstructured":"Qu S, Huang J, Liu J, Wang H. Prognostic significance of cancer stemness-associated genes in patients with gliomas. Clin Transl Med. 2020;10(5):e186.","journal-title":"Clin Transl Med"},{"issue":"2","key":"14514_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2011.10.012","volume":"315","author":"LS Piao","year":"2012","unstructured":"Piao LS, Hur W, Kim T-K, Hong SW, Kim SW, Choi JE, et al. CD133\u2009+\u2009liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett. 2012;315(2):129\u201337.","journal-title":"Cancer Lett"},{"issue":"7120","key":"14514_CR90","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/442756a","volume":"444","author":"W BaoS","year":"2006","unstructured":"BaoS W. Gliomastem cellspromote radioresistancebypreferentialactivationofthednadamageresponse. Nature. 2006;444(7120):756.","journal-title":"Nature"},{"issue":"5","key":"14514_CR91","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3171\/2013.7.JNS122417","volume":"119","author":"K Tamura","year":"2013","unstructured":"Tamura K, Aoyagi M, Ando N, Ogishima T, Wakimoto H, Yamamoto M, Ohno K. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J Neurosurg. 2013;119(5):1145\u201355.","journal-title":"J Neurosurg"},{"key":"14514_CR92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2015.08.007","volume":"155","author":"DR Sudhan","year":"2015","unstructured":"Sudhan DR, Siemann DW. Cathepsin L targeting in cancer treatment. Pharmacol Ther. 2015;155:105\u201316.","journal-title":"Pharmacol Ther"},{"issue":"9","key":"14514_CR93","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/aps.2015.36","volume":"36","author":"Q-q Zhang","year":"2015","unstructured":"Zhang Q-q, Wang W-j, Li J, Yang N, Chen G, Wang Z, Liang Z-q. Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2\/M cell cycle arrest and DNA damage. Acta Pharmacol Sin. 2015;36(9):1113\u201325.","journal-title":"Acta Pharmacol Sin"},{"issue":"24","key":"14514_CR94","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.3390\/cells11244108","volume":"11","author":"X Ding","year":"2022","unstructured":"Ding X, Zhang C, Chen H, Ren M, Liu X. Cathepsins trigger cell death and regulate radioresistance in glioblastoma. Cells. 2022;11(24):4108.","journal-title":"Cells"},{"issue":"12","key":"14514_CR95","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/ijms17121982","volume":"17","author":"DJ III Olivos","year":"2016","unstructured":"Olivos DJ III, Mayo LD. Emerging non-canonical functions and regulation by p53: p53 and stemness. Int J Mol Sci. 2016;17(12):1982.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"14514_CR96","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/138920371604150429152328","volume":"16","author":"M Bai","year":"2015","unstructured":"Bai M, Ma X, Li X, Wang X, Mei Q, Li X, et al. The accomplices of NF-\u03baB lead to radioresistance. Curr Protein Pept Sci. 2015;16(4):279\u201394.","journal-title":"Curr Protein Pept Sci"},{"issue":"11","key":"14514_CR97","first-page":"4785","volume":"9","author":"H-H Wang","year":"2017","unstructured":"Wang H-H, Liao C-C, Chow N-H, Huang LL-H, Chuang J-I, Wei K-C, Shin J-W. Whether CD44 is an applicable marker for glioma stem cells. Am J Translational Res. 2017;9(11):4785.","journal-title":"Am J Translational Res"},{"issue":"7120","key":"14514_CR98","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"S Piccirillo","year":"2006","unstructured":"Piccirillo S, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444(7120):761\u20135.","journal-title":"Nature"},{"issue":"1","key":"14514_CR99","doi-asserted-by":"publisher","first-page":"17663","DOI":"10.1038\/srep17663","volume":"5","author":"J Yuan","year":"2015","unstructured":"Yuan J, Zhang F, Niu R. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer. Sci Rep. 2015;5(1):17663.","journal-title":"Sci Rep"},{"issue":"3","key":"14514_CR100","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2217\/fon.12.1","volume":"8","author":"Y Li","year":"2012","unstructured":"Li Y, Zhang S, Huang S. FoxM1: a potential drug target for glioma. Future Oncol. 2012;8(3):223\u20136.","journal-title":"Future Oncol"},{"issue":"6","key":"14514_CR101","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/stem.1358","volume":"31","author":"K Joshi","year":"2013","unstructured":"Joshi K, Banasavadi-Siddegowda Y, Mo X, Kim S-H, Mao P, Kig C, et al. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Stem Cells. 2013;31(6):1051\u201363.","journal-title":"Stem Cells"},{"key":"14514_CR102","doi-asserted-by":"publisher","first-page":"608082","DOI":"10.3389\/fonc.2020.608082","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang J, Wang Y, Liu G, Li H, Yu J, et al. MELK Inhibition effectively suppresses growth of glioblastoma and cancer stem-like cells by blocking AKT and FOXM1 pathways. Front Oncol. 2021;10:608082.","journal-title":"Front Oncol"},{"issue":"24","key":"14514_CR103","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","volume":"69","author":"M-L Suv\u00e0","year":"2009","unstructured":"Suv\u00e0 M-L, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle J-C, et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009;69(24):9211\u20138.","journal-title":"Cancer Res"},{"issue":"8","key":"14514_CR104","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1172\/JCI89092","volume":"127","author":"J Wang","year":"2017","unstructured":"Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim S-H, et al. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. J Clin Invest. 2017;127(8):3075\u201389.","journal-title":"J Clin Invest"},{"issue":"5","key":"14514_CR105","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/cells10051201","volume":"10","author":"HR Ferguson","year":"2021","unstructured":"Ferguson HR, Smith MP, Francavilla C. Fibroblast growth factor receptors (FGFRs) and noncanonical partners in cancer signaling. Cells. 2021;10(5):1201.","journal-title":"Cells"},{"key":"14514_CR106","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00018-012-1073-7","volume":"70","author":"AS Nikonova","year":"2013","unstructured":"Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL, Golemis EA. Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci. 2013;70:661\u201387.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"14514_CR107","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms23010523","volume":"23","author":"S Ueno","year":"2022","unstructured":"Ueno S, Sudo T, Hirasawa A, ATM. Functions of ATM kinase and its relevance to hereditary tumors. Int J Mol Sci. 2022;23(1):523.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"14514_CR108","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/or.2017.5665","volume":"38","author":"Y Li","year":"2017","unstructured":"Li Y, Li L, Wu Z, Wang L, Wu Y, Li D, et al. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo. Oncol Rep. 2017;38(1):325\u201335.","journal-title":"Oncol Rep"},{"issue":"1","key":"14514_CR109","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molonc.2014.08.003","volume":"9","author":"R Carruthers","year":"2015","unstructured":"Carruthers R, Ahmed SU, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers AJ. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase. Mol Oncol. 2015;9(1):192\u2013203.","journal-title":"Mol Oncol"},{"issue":"8","key":"14514_CR110","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1002\/cam4.1614","volume":"7","author":"X Zhu","year":"2018","unstructured":"Zhu X, Wang Y, Tan L, Fu X. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy. Cancer Med. 2018;7(8):3812\u20139.","journal-title":"Cancer Med"},{"issue":"1","key":"14514_CR111","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cam4.3574","volume":"10","author":"S Qu","year":"2021","unstructured":"Qu S, Chen Z, Liu B, Liu J, Wang H. N6-methyladenine\u2010related genes affect biological behavior and the prognosis of glioma. Cancer Med. 2021;10(1):98\u2013108.","journal-title":"Cancer Med"},{"key":"14514_CR112","doi-asserted-by":"crossref","unstructured":"Toyota M, Issa J-PJ, editors. CpG island methylator phenotypes in aging and cancer. Seminars in cancer biology. Elsevier. 1999;9(5):349\u2013357.","DOI":"10.1006\/scbi.1999.0135"},{"issue":"5","key":"14514_CR113","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010;17(5):510\u201322.","journal-title":"Cancer Cell"},{"issue":"3","key":"14514_CR114","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell. 2016;164(3):550\u201363.","journal-title":"Cell"},{"issue":"1","key":"14514_CR115","doi-asserted-by":"publisher","first-page":"1902071","DOI":"10.1080\/2162402X.2021.1902071","volume":"10","author":"A Yin","year":"2021","unstructured":"Yin A, Shang Z, Etcheverry A, He Y, Aubry M, Lu N, et al. Integrative analysis identifies an immune-relevant epigenetic signature for prognostication of non-G-CIMP glioblastomas. Oncoimmunology. 2021;10(1):1902071.","journal-title":"Oncoimmunology"},{"issue":"4","key":"14514_CR116","doi-asserted-by":"publisher","first-page":"e14465","DOI":"10.1111\/cns.14465","volume":"30","author":"BB Liang","year":"2024","unstructured":"Liang BB, Wang YH, Huang JJ, Lin S, Mao GC, Zhou ZJ, et al. Genome-wide DNA methylation analysis identifies potent CpG signature for temzolomide response in non\u2010G\u2010CIMP glioblastomas with unmethylated MGMT promoter: MGMT\u2010dependent roles of GPR81. CNS Neurosci Ther. 2024;30(4):e14465.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"14514_CR117","first-page":"6345160","volume":"2022","author":"B Li","year":"2022","unstructured":"Li B, Wang J, Liu F, Li R, Hu W, Etcheverry A, et al. A novel pseudogene methylation signature to predict Temozolomide outcome in non-G\u2010CIMP glioblastomas. J Oncol. 2022;2022(1):6345160.","journal-title":"J Oncol"},{"issue":"9","key":"14514_CR118","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1158\/1078-0432.CCR-14-2737","volume":"21","author":"M Weller","year":"2015","unstructured":"Weller M, Tabatabai G, K\u00e4stner B, Felsberg J, Steinbach JP, Wick A, et al. MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified Temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial. Clin Cancer Res. 2015;21(9):2057\u201364.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"14514_CR119","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"W Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012;13(7):707\u201315.","journal-title":"Lancet Oncol"},{"issue":"12","key":"14514_CR120","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.3390\/ijms24129825","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Fritah S, Nazarov PV, Kaoma T, Van Dyck E. Impact of IDH mutations, the 1p\/19q co-deletion and the G-CIMP status on alternative splicing in diffuse gliomas. Int J Mol Sci. 2023;24(12):9825.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"14514_CR121","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2741\/3952","volume":"17","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Dutta A, Abounader R. The role of MicroRNAs in glioma initiation and progression. Front Biosci (Landmark Ed). 2012;17(2):700\u201312.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"14514_CR122","doi-asserted-by":"publisher","first-page":"151436","DOI":"10.1016\/j.anndiagpath.2019.151436","volume":"44","author":"Z Li","year":"2020","unstructured":"Li Z, Ye L, Wang L, Quan R, Zhou Y, Li X. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients. Ann Diagn Pathol. 2020;44:151436.","journal-title":"Ann Diagn Pathol"},{"issue":"13","key":"14514_CR123","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.1111\/jcmm.15377","volume":"24","author":"JH Zhang","year":"2020","unstructured":"Zhang JH, Hou R, Pan Y, Gao Y, Yang Y, Tian W, Zhu YB. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma. J Cell Mol Med. 2020;24(13):7504\u201314.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"14514_CR124","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.18632\/aging.103189","volume":"12","author":"W Lin","year":"2020","unstructured":"Lin W, Huang Z, Xu Y, Chen X, Chen T, Ye Y, et al. A three-lncrna signature predicts clinical outcomes in low-grade glioma patients after radiotherapy. Aging. 2020;12(10):9188\u2013204.","journal-title":"Aging"},{"key":"14514_CR125","doi-asserted-by":"publisher","first-page":"622880","DOI":"10.3389\/fonc.2021.622880","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Cai S, Li H, Gu J, Tian Y, Cao J, et al. Developing a LncRNA signature to predict the radiotherapy response of Lower-Grade gliomas using Co-expression and CeRNA network analysis. Front Oncol. 2021;11:622880.","journal-title":"Front Oncol"},{"issue":"16","key":"14514_CR126","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.4161\/cc.6.16.4526","volume":"6","author":"JK Gillies","year":"2007","unstructured":"Gillies JK, Lorimer IAJ. Regulation of p27Kip1 by miRNA 221\/222 in glioblastoma. Cell Cycle. 2007;6(16):2005\u20139.","journal-title":"Cell Cycle"},{"key":"14514_CR127","doi-asserted-by":"publisher","first-page":"117974","DOI":"10.1016\/j.lfs.2020.117974","volume":"256","author":"R Raviraj","year":"2020","unstructured":"Raviraj R, Nagaraja SS, Selvakumar I, Mohan S, Nagarajan D. The epigenetics of brain tumors and its modulation during radiation: A review. Life Sci. 2020;256:117974.","journal-title":"Life Sci"},{"issue":"1","key":"14514_CR128","doi-asserted-by":"publisher","first-page":"e0295698","DOI":"10.1371\/journal.pone.0295698","volume":"19","author":"P Azimi","year":"2024","unstructured":"Azimi P, Karimpour M, Yazdanian T, Totonchi M, Ahmadiani A. Comprehensive somatic mutational analysis in glioblastoma: implications for precision medicine approaches. PLoS One. 2024;19(1):e0295698.","journal-title":"PLoS One"},{"issue":"2","key":"14514_CR129","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.crad.2022.08.138","volume":"78","author":"A Mahajan","year":"2023","unstructured":"Mahajan A, Sahu A, Ashtekar R, Kulkarni T, Shukla S, Agarwal U, Bhattacharya K. Glioma radiogenomics and artificial intelligence: road to precision cancer medicine. Clin Radiol. 2023;78(2):137\u201349.","journal-title":"Clin Radiol"},{"issue":"10","key":"14514_CR130","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00066-014-0638-9","volume":"190","author":"A Fiorentino","year":"2014","unstructured":"Fiorentino A, Simeon V, Tini P, Chiumento C, Pirtoli L, Salvatore M, Storto G. Clinical radiobiology of glioblastoma multiforme. Strahlenther Onkol. 2014;190(10):925.","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"14514_CR131","doi-asserted-by":"publisher","first-page":"e0217881","DOI":"10.1371\/journal.pone.0217881","volume":"14","author":"PA Jablonska","year":"2019","unstructured":"Jablonska PA, Diez-Valle R, P\u00e9rez-Larraya JG, Moreno-Jimenez M, Idoate M\u00c1, Arbea L, et al. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS One. 2019;14(6): e0217881.","journal-title":"PLoS One"},{"issue":"11","key":"14514_CR132","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3390\/jpm11111145","volume":"11","author":"F Gregucci","year":"2021","unstructured":"Gregucci F, Surgo A, Bonaparte I, Laera L, Ciliberti MP, Carbonara R, et al. Poor-prognosis patients affected by glioblastoma: retrospective study of hypofractionated radiotherapy with simultaneous integrated boost and concurrent\/adjuvant temozolomide. J Pers Med. 2021;11(11): 1145.","journal-title":"J Pers Med"},{"issue":"1","key":"14514_CR133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11547-017-0806-y","volume":"123","author":"S Scoccianti","year":"2018","unstructured":"Scoccianti S, Krengli M, Marrazzo L, Magrini SM, Detti B, Fusco V, et al. Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus Temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the brain study group of the Italian association of radiation oncology (AIRO). Radiol Med. 2018;123(1):48\u201362.","journal-title":"Radiol Med"},{"issue":"4","key":"14514_CR134","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/brain\/awac450","volume":"146","author":"D Qi","year":"2022","unstructured":"Qi D, Li J, Quarles CC, Fonkem E, Wu E. Assessment and prediction of glioblastoma therapy response: challenges and opportunities. Brain. 2022;146(4):1281\u201398.","journal-title":"Brain"},{"issue":"4","key":"14514_CR135","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s12253-014-9833-3","volume":"20","author":"K Eder","year":"2014","unstructured":"Eder K, Kalman B. Molecular heterogeneity of glioblastoma and its clinical relevance. Pathol Oncol Res. 2014;20(4):777\u201387.","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"14514_CR136","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11060-020-03643-0","volume":"149","author":"JH McAbee","year":"2020","unstructured":"McAbee JH, Degorre-Kerbaul C, Valdez K, Wendler A, Shankavaram UT, Watts C, et al. Detection of glioblastoma intratumor heterogeneity in radiosensitivity using patient-derived neurosphere cultures. J Neurooncol. 2020;149(3):383\u201390.","journal-title":"J Neurooncol"},{"key":"14514_CR137","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2020.02.025","volume":"477","author":"LS Hu","year":"2020","unstructured":"Hu LS, Hawkins-Daarud A, Wang L, Li J, Swanson KR. Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett. 2020;477:97\u2013106.","journal-title":"Cancer Lett"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14514-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T10:02:47Z","timestamp":1751709767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14514-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14514"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14514-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1146"}}